Latest Current Report
Filed: 2026-01-12
Key Insights
- Zimmer Biomet announced the resignation of Mark Bezjak, a named executive officer, effective January 16, 2026 to pursue another business opportunity. This represents a change in the company's leadership team.
- The company has several debt instruments outstanding, including 2.425% Notes due 2026, 1.164% Notes due 2027, and 3.518% Notes due 2032, which are traded on the New York Stock Exchange.
- The filing does not provide any details on the company's financial performance or any other material updates, suggesting this is a routine announcement.